COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS Read more about COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS Patent Cooperation TreatyPCT/US2021/032782Filed on 2021-05-17
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection BrazilBR122021011713-6Filed on 2021-06-16
Compositions And Methods For Treating Bacterial Infections Read more about Compositions And Methods For Treating Bacterial Infections US Patent 11,865,168Filed on 2020-12-30
METHODS OF PRODUCING T CELL POPULATIONS ENRICHED FOR STABLE REGULATORY T-CELLS Read more about METHODS OF PRODUCING T CELL POPULATIONS ENRICHED FOR STABLE REGULATORY T-CELLS US Application 17/371,589Filed on 2021-07-09
STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF Read more about STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF China202110772479.0Filed on 2015-05-27
Replication-Competent Adenovirus Type 4-HIV Env Vaccines And Their Use Read more about Replication-Competent Adenovirus Type 4-HIV Env Vaccines And Their Use Patent Cooperation TreatyPCT/US2021/045389Filed on 2021-08-10
USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS Read more about USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US Application 17/157,761Filed on 2021-01-25
LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS Read more about LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS Patent Cooperation TreatyPCT/US2021/036030Filed on 2021-06-04
Adjuvanted Stabilized Stem Hemagglutinin Nanoparticles And Methods Of Using The Same To Induce Broadly Neutralizing Antibodies Against Influenza Read more about Adjuvanted Stabilized Stem Hemagglutinin Nanoparticles And Methods Of Using The Same To Induce Broadly Neutralizing Antibodies Against Influenza Patent Cooperation TreatyPCT/US2021/032252Filed on 2021-05-13
TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS Read more about TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS Hong Kong62021032425.2Filed on 2019-02-19